share_log

藥明康德：翌日披露報表

WUXI APPTEC: Next Day Disclosure Return

香港交易所 ·  Apr 12 17:16
Summary by Futu AI
無錫藥明康德新藥開發股份有限公司於2024年3月8日至4月12日期間，通過上海證券交易所回購股份。該公司在此期間共回購了多批A股股份，總計回購股份數目達到數百萬股。回購價格與市場價格相比，呈現出不同程度的折讓或溢價。此舉動是根據相關規則進行，並於2024年4月12日向香港聯合交易所有限公司披露。公司董事李革確認，所有交易均按照規定執行，並且已經獲得董事會的正式授權批准。
無錫藥明康德新藥開發股份有限公司於2024年3月8日至4月12日期間，通過上海證券交易所回購股份。該公司在此期間共回購了多批A股股份，總計回購股份數目達到數百萬股。回購價格與市場價格相比，呈現出不同程度的折讓或溢價。此舉動是根據相關規則進行，並於2024年4月12日向香港聯合交易所有限公司披露。公司董事李革確認，所有交易均按照規定執行，並且已經獲得董事會的正式授權批准。
Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. repurchased shares through the Shanghai Stock Exchange from March 8 to April 12, 2024. The company repurchased multiple A shares during this period, bringing the total number of repurchases to millions of shares. The repurchase price presents a different degree of discount or premium compared to the market price. This action was made in accordance with the relevant rules and disclosed to the Hong Kong Stock Exchange Limited on 12 April 2024. The Director of the Company, Li Gem, confirmed that all transactions have been executed in accordance with the requirements and have been formally authorized by the Board of Directors.
Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. repurchased shares through the Shanghai Stock Exchange from March 8 to April 12, 2024. The company repurchased multiple A shares during this period, bringing the total number of repurchases to millions of shares. The repurchase price presents a different degree of discount or premium compared to the market price. This action was made in accordance with the relevant rules and disclosed to the Hong Kong Stock Exchange Limited on 12 April 2024. The Director of the Company, Li Gem, confirmed that all transactions have been executed in accordance with the requirements and have been formally authorized by the Board of Directors.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.